We found out how much typical employees at 23 biotechs make

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, back at the helm of this daily newsletter. Today in healthcare news:

• We found out how much typical employees at 23 biotechs make;
• Two major health systems are making a big bet on hospital-level care at home;
• A CDC panel signs off on Pfizer's shot for 12- to 15-year-olds.

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

Employees at top biotech companies can get paid up to $701,000. Here's where workers made the most in 2020.

• Insider analyzed median employee pay at more than 100 drug companies to identify the best-paying firms.
• Here are the 23 best-paying biotechs, which all paid over $300,000 to their typical worker in 2020.
• At the top are TG Therapeutics ($701,000), Reata Pharmaceuticals ($568,580), and Kodiak Sciences ($517,381).

Find out the median pay at 23 biotechs>>

Why two major health systems are investing $100 million in a startup that helps doctors provide hospital-level care at home

• Kaiser Permanente and Mayo Clinic are investing $100 million to scale in-home care startup Medically Home.
• The investment comes as doctors and hospitals embrace remote care amid the COVID-19 pandemic.
• Investor interest in a crop of companies helping hospitals provide in-home care is growing.

Get the full story>>

CDC panel OK's Pfizer for 12- to 15-year-olds after safety review

• A panel of CDC advisors voted Wednesday to allow Pfizer's vaccine to be administered to teens aged 12-15.
• The vote by the independent committee of 15 experts was near unanimous, with 14 in favor and one recusal.
• "This is another way to get closer to ending this horrible pandemic," one advisor said.

Shots could go in arms of young teens starting today>>

More stories we're reading:

• A vaccinated New Jersey retirement community is living out your post-pandemic dreams (Insider)
• TJ Parker, who co-founded PillPack, lays out what's next for Amazon's pharmacy ambitions (Stat News)
• Back at work with no masks or social distancing, Australians reveal what it's really like to return to the office (Insider)
• The average "cost of dying" in the US, by state (Axios)

- Lydia